|
Valoración de DCF de Scholar Rock Holding Corporation (SRRK)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Scholar Rock Holding Corporation (SRRK) Bundle
Ya sea que sea un inversor o analista, esta calculadora DCF de Scholar Rock Holding Corporation (SRRK) es su recurso de referencia para una valoración precisa. Precedidos con datos reales de Scholar Rock, puede ajustar las previsiones y observar los efectos en tiempo real.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.4 | 18.8 | 33.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 22.16 | 76.41 | -100 | 0 | -0.3584 | -0.3584 | -0.3584 | -0.3584 | -0.3584 |
| EBITDA | -85.4 | -127.3 | -131.4 | -168.5 | -252.1 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -554.35 | -676.52 | -395.82 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | 3.9 | 9.0 | 9.9 | 2.8 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 25.13 | 47.96 | 29.78 | 100 | 100 | 60.57 | 60.57 | 60.57 | 60.57 | 60.57 |
| EBIT | -89.3 | -136.3 | -141.3 | -171.3 | -252.1 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -579.48 | -724.48 | -425.6 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | 341.0 | 253.0 | 315.4 | 279.9 | 437.3 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | 2.7 | 1.1 | 2.2 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 0 | 0 | 8.24 | 100 | 100 | 41.65 | 41.65 | 41.65 | 41.65 | 41.65 |
| Inventories | .0 | .0 | -2.7 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | -8.24 | 100 | 100 | 38.35 | 38.35 | 38.35 | 38.35 | 38.35 |
| Accounts Payable | 3.4 | 4.4 | 4.0 | 3.5 | 10.1 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 22.13 | 23.57 | 12.03 | 100 | 100 | 51.55 | 51.55 | 51.55 | 51.55 | 51.55 |
| Capital Expenditure | -4.1 | -5.2 | -1.1 | -.1 | -.1 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -26.54 | -27.89 | -3.21 | 100 | 100 | -11.53 | -11.53 | -11.53 | -11.53 | -11.53 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -87.7 | -136.3 | -138.3 | -171.3 | -252.1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -84.5 | -131.5 | -129.9 | -170.1 | -246.6 | -7.9 | .0 | .0 | .0 | .0 |
| WACC, % | 6.39 | 6.39 | 6.39 | 6.39 | 6.39 | 6.39 | 6.39 | 6.39 | 6.39 | 6.39 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -7.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -7 | |||||||||
| Net Debt | -113 | |||||||||
| Equity Value | 105 | |||||||||
| Diluted Shares Outstanding, MM | 100 | |||||||||
| Equity Value Per Share | 1.05 |
What You Will Get
- Real SRRK Financial Data: Pre-filled with Scholar Rock Holding Corporation’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Scholar Rock Holding Corporation’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Research Inputs: Adjust essential variables such as revenue projections, R&D investment, and operational costs.
- Instant DCF Analysis: Automatically computes intrinsic value, NPV, and additional metrics in real-time.
- High-Precision Estimates: Leverages Scholar Rock's actual financial data for accurate valuation results.
- Effortless Scenario Testing: Evaluate various assumptions and analyze results with ease.
- Efficiency Booster: Streamline the valuation process without the hassle of creating intricate models from the ground up.
How It Works
- Download the Template: Gain immediate access to the Excel-based SRRK DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model will automatically recalculate Scholar Rock’s intrinsic value.
- Test Scenarios: Explore different assumptions to see how they impact potential valuation changes.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for Scholar Rock Holding Corporation (SRRK)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for SRRK.
- Flexible Inputs: Modify the yellow-highlighted cells to explore different financial scenarios for SRRK.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Scholar Rock Holding Corporation.
- Preloaded Information: Access to historical and projected data for precise calculations.
- Expert-Level Tool: Perfect for financial analysts, investors, and consultants focusing on SRRK.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Scholar Rock Holding Corporation (SRRK) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Scholar Rock Holding Corporation (SRRK).
- Consultants: Deliver professional valuation insights on Scholar Rock Holding Corporation (SRRK) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Scholar Rock Holding Corporation (SRRK) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Scholar Rock Holding Corporation (SRRK).
What the Template Contains
- Preloaded SRRK Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.